Status:
RECRUITING
Genome-based Management of Patients in Precision Medicine (Ge-Med) Towards a Genomic Health Program
Lead Sponsor:
University Hospital Tuebingen
Conditions:
Rare Diseases
Genetic Predisposition to Disease
Eligibility:
All Genders
Phase:
NA
Brief Summary
The GE-MED APPROACH project will enroll patients (n = appr. 12.000) with unclear molecular cause of the disease, suspected genetic cause of the disease without detailed molecular analysis like Whole E...
Eligibility Criteria
Inclusion
- Unclear molecular cause of the disease
- Suspected genetic cause of the disease
Exclusion
- Missing informed consent of the patient and if applicable the legal representative
- Previously performed WES or panel analysis
Key Trial Info
Start Date :
June 1 2021
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
July 1 2027
Estimated Enrollment :
12000 Patients enrolled
Trial Details
Trial ID
NCT04760522
Start Date
June 1 2021
End Date
July 1 2027
Last Update
November 29 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Hospital Tübingen
Tübingen, Germany, 72076